Association of serum vitamin C concentrations with Alzheimer's disease mortality among U.S. adults

Li Zhou,Ting Wang,Dan Chen,Guangwen Cheng,Wenfang Li,Xiaoli Cai,Jingling Liao,Wei Bao,Shuang Rong

DOI: https://doi.org/10.1080/1028415x.2024.2403900

2024-11-17

Nutritional Neuroscience

Abstract:Background The association between vitamin C status and Alzheimer's disease (AD) mortality remains unclear.

neurosciences,nutrition & dietetics

What problem does this paper attempt to address?

Association of Serum Vitamin C Concentrations with Alzheimer’s Disease Mortality among U.S. Adults

Li Zhou,Ting Wang,Dan Chen,Guangwen Cheng,Wenfang Li,Xiaoli Cai,Jingling Liao,Wei Bao,Shuang Rong

DOI: https://doi.org/10.1080/1028415x.2024.2403900

2024-01-01

Nutritional Neuroscience

Abstract:BACKGROUND:The association between vitamin C status and Alzheimer's disease (AD) mortality remains unclear. METHODS:A total of 4864 adults aged 60 years or above from the National Health and Nutrition Examination Survey III 1988-1994 were included in this study. Serum vitamin C levels were measured by the fully automated electrochemiluminescence immunoassay. Death and underlying causes of death were ascertained by linkage to death records through December 31, 2019. Cox proportional hazards regression models were used to evaluate the association between serum vitamin C and AD mortality. RESULTS:During 65,251 person-years of follow-up (a median follow-up of 12.0 years), 158 deaths occurred from AD. After adjustment for age, sex, race/ethnicity, socioeconomic status, lifestyle and dietary factors, body mass index, baseline diseases and vitamin C supplement use, compared with participants with deficiency serum vitamin C concentrations (< 53 µmol/L), the multivariate-adjusted HR (95% CI) for AD mortality was 0.62 (0.39-0.99) for participants with adequate serum vitamin C concentrations (53-70 µmol/L) and 0.64 (0.34-1.18) for participants with saturate serum vitamin C concentrations (> 70 µmol/L). CONCLUSION:In this nationally representative sample of US adults, higher serum vitamin C was significantly associated with lower risk of AD mortality. These findings suggest that maintaining adequate vitamin C status may aid in lowering AD mortality risk.
Oxidative Stress Markers and Metal Ions Are Correlated with Cognitive Function in Alzheimer’s Disease

Zhengping Pu,Wenjie Xu,Yong Lin,Jincai He,Manli Huang

DOI: https://doi.org/10.1177/1533317517709549

2017-01-01

American Journal of Alzheimer s Disease & Other Dementias®

Abstract:We investigated oxidative stress markers and metal ions in patients with Alzheimer’s disease (AD). The serum levels of ceruloplasmin (CER), C-reactive protein (CRP), uric acid (UA), homocysteine (Hcy), copper, iron, and zinc were determined in 125 patients with AD (mild, n = 2 8; moderate, n = 42; and severe, n = 55) and 40 healthy control (HC) participants. Compared to HC, CER and UA levels were significantly lower in moderate and severe AD groups, whereas CRP and Hcy levels were significantly higher in the severe AD group. Copper level was significantly higher in moderate and severe AD groups than the other groups. Compared to HC, iron level was significantly higher in patients with AD, whereas zinc level was significantly lower in patients with AD. In patients with AD, the severity of cognitive impairment was positively correlated with CER, UA, and zinc levels, whereas it was negatively correlated with copper level. Taken together, our findings provide a novel approach to assess AD progression.
The Relation of Serum Vitamin C Concentrations with Alzheimer's Disease Mortality in a National Cohort of Community-Dwelling Elderly Adults

Duke Appiah,Elyvine Ingabire-Gasana,Linda Appiah,Jeanne Yang

DOI: https://doi.org/10.3390/nu16111672

IF: 5.9

2024-05-30

Nutrients

Abstract:The relation of vitamin C with Alzheimer's disease (AD) is equivocal. The aim of this study was to assess the relation of serum vitamin C levels with AD-related mortality, and to evaluate the threshold beyond which the potential benefits of higher serum concentrations of vitamin C for AD mortality ceases. The cohort consisted of 4504 adults aged ≥60 years enrolled in the National Health and Nutrition Examination Survey who had serum measures of vitamin C and no cognitive impairment at baseline (1988–1994) and were followed-up for mortality until 2019. Vitamin C was assayed from fasting blood samples using isocratic high-performance liquid chromatography. At baseline, the mean age of participants was 70 years, with 42.7% being men. At the end of follow-up (median: 15 years), the AD mortality rate was 2.4 per 1000 person-years. In the Cox regression models, compared to participants in the lowest tertile of serum vitamin C ( 0.98 mg/dL) had a lower risk of AD mortality (hazard ratio: 0.44, 95% confidence intervals: 0.25–0.77) after adjusting for sociodemographic factors, behavior/lifestyle factors, prevalent health conditions, and dietary vitamin C intake. In dose–response analysis using restricted cubic splines, vitamin C concentrations beyond 2.3 mg/dL were associated with the elevated risk of AD-related mortality. The findings from this national sample of community-dwelling elderly adults suggest that higher levels of serum vitamin C are associated with slower AD disease progression, although levels beyond the normal reference values were associated with a higher risk of AD mortality.

nutrition & dietetics
Associations of Serum Albumin with Disability in Activities of Daily Living, Mobility and Objective Physical Functioning Regardless of Vitamin D: Cross-Sectional Findings from the Chinese Longitudinal Healthy Longevity Survey.

Xueqin Li,Xingqi Cao,Zhimin Ying,Jingyun Zhang,Xiaoyi Sun,Emiel O. Hoogendijk,Zuyun Liu

DOI: https://doi.org/10.3389/fnut.2022.809499

IF: 5

2022-01-01

Frontiers in Nutrition

Abstract:Objective:To examine the associations of serum albumin, a nutrition indicator, with disability in activities of daily living (ADL), mobility, and objective physical functioning among Chinese older adults.Materials and Methods:Cross-sectional data of 2233 older adults (≥65 years) who participated in the 2011/2012 main survey of the Chinese Longitudinal Healthy Longevity Survey (CLHLS) and the 2012 biomarker sub-study was used. Serum albumin was measured by immunoturbidimetric assay. Physical functioning included subjectively (ADL and mobility) and objectively measured disability (standing up from a chair, picking up a book from the floor, and turning around 360°). Multivariable logistic regression models were performed.Results:After adjusting for age and sex, compared with participants in the lowest quartile group of serum albumin, those in the highest quartile group had 45% lower odds of disability in ADL (odds ratio [OR]: 0.55; 95% confidence interval [CI]: 0.38, 0.80); 48% lower odds of disability in mobility (OR: 0.52; 95% CI: 0.38, 0.71); 46% lower odds of disability in standing up from a chair (OR: 0.54; 95% CI: 0.34, 0.85); and 37% lower odds of disability in picking up a book from the floor (OR: 0.63; 95% CI: 0.40, 0.97). We did not observe a statistically significant interaction effect between serum albumin and vitamin D on disability in physical functioning.Conclusion:Serum albumin level was associated with physical functioning among Chinese older adults, regardless of vitamin D level. The findings indicate that appropriate management of poor nutritional status, in particular low serum albumin levels, may contribute to maintaining physical functioning in older adults.
Serum 25-Hydroxyvitamin D in Relation to Disability in Activities of Daily Living, Mobility, and Objective Physical Functioning among Chinese Older Adults.

Xingqi Cao,Zhimin Ying,Xueqin Li,Jingyun Zhang,Emiel O. Hoogendijk,Zuyun Liu

DOI: https://doi.org/10.1016/j.exger.2021.111290

IF: 4.253

2021-01-01

Experimental Gerontology

Abstract:Objectives: Vitamin D deficiency is common among older adults, but its association with physical function is not fully understood. The aim of this study was to investigate the associations between serum 25-hydroxyvitamin D and disability in activities of daily living (ADL), mobility, and objective physical functioning among Chinese older adults. Methods: We used cross-sectional data of 2225 older adults (>= 65 years) who participated in the 2011/2012 main survey of the Chinese Longitudinal Healthy Longevity Survey (CLHLS) and the 2012 biomarker sub-study. Serum levels of 25-hydroxyvitamin D were measured by enzyme immunoassay. Outcomes included ADL disability, mobility disability, and disability in three objective physical examinations (standing-up from a chair, picking-up a book from the floor, and turning-around 360 degrees). Results: The multiple regression models suggested that participants in the serum 25-hydroxyvitamin D deficiency group had higher odds of ADL disability (OR: 4.08; 95% confidence interval (CI): 2.81, 5.92), mobility disability (OR: 1.59; 95% CI: 1.05, 2.41), and disability in standing-up from a chair (OR: 2.43; 95% CI: 1.60, 3.69), picking up a book from the floor (OR: 3.09; 95% CI: 2.07, 4.60), and turning-around 360 degrees (OR: 3.09; 95% CI: 2.07, 4.60). Subgroup analyses revealed that some of the above associations (particularly those with mobility disability and disability in turning-around 360 degrees) were only statistically significant among the oldest-old. Conclusions: Among the oldest-old in China, serum 25-hydroxyvitamin D deficiency was associated with disability in ADL, mobility, and objective physical functioning, highlighting the importance of managing the serum 25-hydroxyvitamin D level to promote healthy aging.
The Impact of Plasma Vitamin C Levels on the Risk of Cardiovascular Diseases and Alzheimer's Disease: A Mendelian Randomization Study.

Lu Chen,Xingang Sun,Zhen Wang,Yunlong Lu,Miao Chen,Yuxian He,Hongfei Xu,Liangrong Zheng

DOI: https://doi.org/10.1016/j.clnu.2021.08.020

IF: 7.643

2021-01-01

Clinical Nutrition

Abstract:Background & aims: Previous observational studies have reported associations between plasma vitamin C levels, and cardiovascular diseases (CVDs) and Alzheimer's disease (AD); however, no conclusive results have been obtained. We conducted a Mendelian randomization (MR) study to investigate the causality of vitamin C on the risk of nine CVDs [including coronary artery disease (CAD), myocardial infarction (MI), atrial fibrillation (AF), heart failure (HF), stroke, ischemic stroke (IS), and IS subtypes] and Alzheimer's disease. Methods: Eleven single-nucleotide polymorphisms (SNPs) identified in a recent genome-wide meta analysis (N = 52,018) were used as the instrumental variables for plasma vitamin C levels. The summary level data for CVDs and AD were extracted from consortia and genome-wide association studies (GWAS). We performed MR analyses using the fixed-effects inverse-variance-weighted (IVW) method, weighted median, and MR-Egger approaches. Results: This MR study found suggestive evidence that genetic liability to higher vitamin C levels was associated with a lower risk of cardioembolic stroke [odds ratio (OR, presented per 1 standard deviation increase in plasma vitamin C levels) = 0.773; 95% confidence interval (CI), 0.623-0.959; P = 0.020] and AD (OR = 0.968; 95% CI, 0.946-0.991; P = 0.007) using the fixed-effects IVW method. Sensitivity analysis yielded directionally similar results. A null-association was observed between vitamin C and the other CVDs. Conclusion: Our MR study provided suggestive evidence that higher vitamin C levels were casually associated with a decreased risk of cardioembolic stroke and AD. No evidence was observed to suggest that vitamin C affected the risk of CAD, MI, AF, HF, stroke, IS, large artery stroke, or small vessel stroke. However, well-designed studies are warranted to confirm these results and determine the underlying mechanisms of the causal links. 0 2021 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Association of serum vitamin C with all-cause and cause-specific death: Data from National Health and Nutrition Examination Survey (NHANES 2003-2006)

Tian Tian,Jian Shao,Zhimei Shen,Xueli Sun,Yan Liu,Ling Cao,Yang Geng,Bin Song

DOI: https://doi.org/10.1016/j.nut.2022.111696

IF: 4.893

2022-04-01

Nutrition

Abstract:Purpose: The association between circulating vitamin C level and mortality remains controversial. We aimed to explore the non-linear association of serum vitamin C level with all-cause or cause-specific mortality.Methods: A total of 9,902 US adults from the National Health and Nutrition Examination Survey (NHANES 2003-2006) who had serum vitamin C level were included, and their survival information was retrieved from baseline until 2014 using the national death index. Multivariable Cox proportional hazards models were used to show the risk of all-cause or cause-specific death according to baseline serum vitamin C level. Smooth curve fitting and threshold effect analyses were used to clarify potential nonlinearity.Results: During a median follow-up of 10.6 years, there were 1,558 all-cause deaths, including 320 from cancer, 374 from cardiovascular disease (CVD), and 120 from respiratory diseases. Serum vitamin C level had a U-shaped relationship with all-cause or CVD-associated mortality. Interestingly, serum vitamin C lower than the threshold value (1.06 mg/dL) was negatively associated with all-cause (fully adjusted HR = 0.71, 95% CI, 0.59–0.86) and CVD (fully adjusted HR = 0.70, 95% CI, 0.47–1.03) mortality. In constrast, serum vitamin C higher than the threshold value (1.06 mg/dL) was positively associated with all-cause (fully adjusted HR = 1.33, 95% CI, 1.15–1.54) and CVD (fully adjusted H HR = 1.60, 95% CI, 1.23–2.10) mortality, respectively.Conclusion: Serum vitamin C level showed a U-shaped relationship with all-cause and CVD-associated death among US adults using the NHANES data.

nutrition & dietetics
Combined Associations of Vitamin D and Cognitive Function with All-Cause Mortality among Older Adults in Chinese Longevity Areas: A Prospective Cohort Study.

Miao Dai,Quhong Song,Xiang Wang,Ying Li,Taiping Lin,Rui Liang,Tingting Jiang,Xiaoyu Shu,Ning Ge,Jirong Yue

DOI: https://doi.org/10.3389/fpubh.2023.1024341

IF: 5.2

2023-01-01

Frontiers in Public Health

Abstract:Objectives While both vitamin D deficiency and cognitive impairment have individually been linked to a greater risk of all-cause mortality, the combined effects of these two different conditions have not previously been explored in this context. We aimed to investigate the combined impact of vitamin D concentration and cognitive impairment on all-cause mortality in older adults. Methods The analyzed data were collected from community-dwelling adults ≥65 years of age that were enrolled in the Chinese Longitudinal Healthy Longevity Survey (n = 1,673). The Mini-Mental Status Examination (MMSE) was used to assess cognitive function, while the plasma 25-hydroxyvitamin D [25(OH)D] test was used to assess vitamin D status. The associations between vitamin D concentration, cognitive function, and all-cause mortality were assessed with Cox proportional hazards models. We used restricted cubic splines to examine the dose–response relationship between vitamin D and the risk of all-cause mortality and used joint effect testing to explore interactions between vitamin D concentration and cognitive function. Results During a mean (SD) follow-up of 3.8 (1.9) years, 899 (53.7%) deaths occurred. A negative dose–response relationship was observed between 25(OH)D concentration and cognition impairment at baseline, as well as the odds of all-cause mortality during follow-up. Similarly, cognitive impairment was significantly related to all-cause mortality risk (HR 1.81, 95% CI: 1.54 to 2.12). The combined analyses showed positive associations, with the highest mortality risk observed in older adults with both low vitamin D and cognitive impairment (HR 3.04, 95% CI: 2.40 to 3.86). Moreover, the interaction between 25(OH)D concentration and cognitive function was found to be significant in relation to the risk of mortality (p for interaction <0.001). Conclusion Lower plasma 25(OH)D and cognitive impairment were, respectively, associated with increased all-cause mortality risks. The 25(OH)D concentration and cognitive impairment exhibited a combined additive effect on all-cause mortality among older Chinese adults.
Low and High Homocysteine Are Associated with Mortality Independent of B Group Vitamins but Interactive with Cognitive Status in a Free-Living Elderly Cohort

Li-Li Xiu,Meei-Shyuan Lee,Mark L. Wahlqvist,Rosalind Chia-Yu Chen,Yi-Chen Huang,Kuan-Ju Chen,Duo Li

DOI: https://doi.org/10.1016/j.nutres.2012.09.005

IF: 3.876

2012-01-01

Nutrition Research

Abstract:Hyperhomocysteinemia and cognitive impairment both predict mortality and partly because of dietary associations. We have hypothesized that for, nutritional reasons, homocysteine and cognition may act jointly to determine elder survival. In a Nutrition and Health Survey in Taiwan (1999-2000), some 1412 representative elderly were followed up for mortality up to 10 years. Cognition was assessed by the Short Portable Mental Status Questionnaire. Food and B vitamin intakes with their biomarkers, and plasma homocysteine, were measured at baseline. The possible effects of cognition on homocysteine-associated mortality were ascertained with Cox proportional-hazards models. Homocysteine was higher in those who were older, male, and single, consumed less fish and tea, and with alcohol and smoking. In models adjusted for these variables, when homocysteine exceeded 14.5 μmol/L, mortality was 1.80-fold more than when <9.3 μmol/L (hazard ratio [HR], 1.80; 95% confidence interval [95% CI], 1.20-2.71). P for trend was 0.002 and interactive with sex (P < .002). However, these homocysteine-mortality associations were dependent on cognition (P = .03); adjustment for food intake or nutrient status made little difference. Homocysteine did not predict cognitive impairment (adjusted OR, 1.40; 95% CI = 0.50-3.93). Vitamins B1, B2, and B6 accounted somewhat for cognitive impairment. Cognition predicted mortality, fully adjusted for available covariates and also for homocysteine (HR, 3.66; 95% CI, 1.64-8.20) but interactively with homocysteine. Thus, the B-group vitamin insufficiency and cognitive impairment associations with premature mortality are confirmed. Yet cognition is inter-related with homocysteine in its association with survival in ways not detectably altered by foods or food-derived vitamins.
The Correlation Between Alzheimer Disease and Levels of Serum Folic Acid and Vitamin B_(12)

ZHANG Rong,GU Zhao-xiang,DING Ping

DOI: https://doi.org/10.3969/j.issn.1006-1703.2007.02.006

2007-01-01

Abstract:To investigate the relationship between Alzheimer disease(AD) and the levels of serum folic acid and Vitamin B12(VitB12).The serum folic acid and VitB12 in 77 AD patients and 83 normal controls were measured by automated chemiluminescence system.The results showed the levels of serum folic acid and VitB12 in AD patients was significantly lower than that in the controls(P0.05).The decrease of serum folic acid and VitB12 in AD was significantly higher than those in the controls.The low levels of serum folic acid and VitB12 were correlated with AD,but not related to the degree of dementia.
Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients

Xueping Chen,Yan Huang,Ting Bao,Fu Jia,Ruwei Ou,Qianqian Wei,Yongping Chen,Jiao Liu,Jing Yang,Huifang Shang

DOI: https://doi.org/10.3389/fnagi.2021.790939

IF: 4.8

2022-01-28

Frontiers in Aging Neuroscience

Abstract:Background and Objective Cystatin C is indicated to be involved in the pathogenesis of Alzheimer's disease (AD) and cognitive impairment. Our objective is to examine the serum Cystatin C levels, and to clarify the correlations between serum Cystatin C and cognitive performance in Chinese AD patients. Methods The serum Cystatin C concentrations in AD patients and age, sex, and body mass index (BMI) matched-healthy controls were measured. The cognitive functions of the AD patients were evaluated by using the Mini-mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA). The severity of dementia was determined with clinical dementia rating (CDR). Results A total of 463 AD patients and 1,389 matched healthy subjects were included. AD patients had higher serum Cystatin C than healthy controls. Serum cystatin C levels were correlated with MoCA scores in AD patients. In an ordinal logistic regression model, AD patients with higher serum cystatin C levels had increased odds of severe cognitive dysfunction. Conclusion Our study suggested that AD patients had higher levels of serum cystatin C than age/sex/BMI-matched normal control subjects. Higher serum cystatin C may be associated with worse cognitive performance, but more studies are required to verify such association.

neurosciences,geriatrics & gerontology,gerontology
Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis

Bingyan Chai,Fulin Gao,Ruipeng Wu,Tong Dong,Cheng Gu,Qiaoran Lin,Yi Zhang

DOI: https://doi.org/10.1186/s12883-019-1500-6

2019-11-13

BMC Neurology

Abstract:Abstract Background We aimed to comprehensively explore the associations between serum 25(OH)D deficiency and risk of dementia and Alzheimer’s disease(AD). Methods We systematically searched Pubmed, the Cochrane Library, Embase and the reference lists of pertinent review articles for relevant articles published from database inception up until January 2019. Pooled hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated with random effects models using the Stata 12.0 statistical software package. Results Twelve prospective cohort studies and four cross-sectional studies were included in this meta-analysis. The pooled HRs of dementia and AD, respectively, were 1.32 (95%CI: 1.16, 1.52) and 1.34 (95%CI: 1.13, 1.60) for vitamin D deficiency (< 20 ng/ml). In the subgroup analyses, the pooled HRs of dementia and AD, respectively, were 1.48 (95%CI: 1.19, 1.85) and 1.51 (95%CI: 1.04, 2.18) for moderate vitamin D deficiency (10–20 ng/ml) and 1.20 (95%CI: 0.99, 1.44) and 1.36 (95%CI: 1.01, 1.84) for severe vitamin D deficiency (< 10 ng/ml). Conclusion There are significant associations between vitamin D deficiency and both dementia and AD. There are stronger associations between severe vitamin D deficiency (< 10 ng/ml) and both dementia and AD compared to moderate vitamin D deficiency (10–20 ng/ml).

clinical neurology
Vitamin D Levels and Cognition in Elderly Adults in China.

Choy-Lye Chei,Prassanna Raman,Zhao-Xue Yin,Xiao-Ming Shi,Yi Zeng,David B Matchar

DOI: https://doi.org/10.1111/jgs.13082

2014-01-01

Journal of the American Geriatrics Society

Abstract:OBJECTIVES:To evaluate the association between vitamin D level and cognitive impairment in individuals aged 60 and older.DESIGN:Cross-sectional cohort study.SETTING:Chinese Longitudinal Healthy Longevity Survey, a community-based cohort study in areas in China where the density of centenarians is exceptionally high.PARTICIPANTS:Individuals with mean age of 84.9 ± 12.7 (N = 2,004).MEASUREMENTS:Participants' cognitive state was evaluated using the Mini-Mental State Examination (MMSE). Vitamin D was measured in plasma using an enzyme-linked immunoassay.RESULTS:The cross-sectional association between quartiles of plasma vitamin D level and cognitive impairment (MMSE score <18) was modeled using logistic regressions. Plasma vitamin D levels were lower in individuals with cognitive impairment (31.9 ± 15.3 nmol/L) than in those without (45.6 ± 19.6 nmol/L). There was a reverse association between plasma vitamin D and cognitive impairment. After adjusting for age, sex, chronic conditions, smoking and drinking habits, outdoor activities, depression, and activity of daily living limitations, the association remained significant. The multivariable-adjusted odds ratio for lowest versus highest vitamin D levels was 2.15 (95% confidence interval (CI) = 1.05-4.41) for cognitive impairment, and the multivariable odds ratio associated with a 1-standard deviation decrement in plasma vitamin D was 1.32 (95% CI = 1.00-1.74) for cognitive impairment.CONCLUSION:Low plasma vitamin D levels were associated with greater odds of cognitive impairment. Further prospective studies in Asian populations are needed to examine the causal direction of this association.
Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia

Yang Song,Meina Quan,Tingting Li,Jianping Jia

DOI: https://doi.org/10.3233/JAD-220410

Abstract:Background: Although elevated levels of homocysteine (Hcy) are associated with cognitive impairment and dementia, the relevance of Hcy, vitamin B12, and folate levels to subtypes of dementia are still unknown. Objective: To investigate the changes of Hcy, vitamin B12, and folate levels in mild cognitive impairment (MCI) and subtypes of dementia including Alzheimer's disease (AD), vascular dementia (VaD), frontotemporal dementia (FTD), and Lewy body dementia (LBD), and their relationships with cognitive function and magnetic resonance imaging (MRI) markers. Methods: We measured serum levels of Hcy, vitamin B12, and folate in 257 subjects. Each subject underwent cognitive function assessment and brain MRI test. The Fazekas and temporal lobe atrophy (MTA) visual rating scales were used to assess the degree of white matter hyperintensities and MTA, respectively. Results: Serum levels of Hcy was higher and vitamin B12 was lower in AD, VaD, FTD, and LBD groups than cognitively normal controls. No significant differences of folate levels were found among 6 groups. Hcy levels were positively correlated with MTA total score in AD (r = 0.448, p < 0.001). Vitamin B12 levels were positively correlated with MoCA in VaD (r = 0.497), and negatively correlated with MTA total score in AD (r = - 0.325) (ps < 0.05). Hyperhomocysteinemia may increase the risk of AD (OR = 2.744), VaD (OR = 3.600), and FTD (OR = 3.244) in the adjusted model (ps < 0.05). Conclusion: Hcy and vitamin B12 levels are associated with MTA in AD. Vitamin B12 levels are associated with general cognition in VaD. Hyperhomocysteinemia is a risk factor for not only AD and VaD but also FTD.
Incidental Finding: Urine Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP) and Serum Vitamin D25

Cheng Song,Feng Li,Liu-Yu Wang,Yu-Quan Shi,Zhen-Hai Shen

DOI: https://doi.org/10.3233/JAD-220165

Abstract:Background: National and international experts have been attempting to find diagnostic tools for the early identification of symptoms to facilitate early identification and intervention of the disease. Objective: Detection of urine Alzheimer-associated neuronal thread protein (AD7c-NTP) and serum 25-hydroxyvitamin D (25(OH)D) in the diagnosis of Alzheimer's disease (AD). Methods: Subjects aged >50 years who underwent a physical examination at the Taihu Sanatorium of Jiangsu Province, had no clinical evidence of AD-related issues, and had normal Mini-Mental State Exam and Montreal Cognitive Assessment scores were enrolled in the present study. There were 35 males and 15 females, who were aged 51-91 years. Urine AD7c-NTP levels and serum 25(OH)D concentrations were measured. Results: The Pearson correlation analysis revealed that the urine AD7c-NTP levels in these subjects were negatively correlated with the serum 25(OH)D concentrations (r = -0.460, p < 0.001). Conclusion: Combined with previous studies, it was considered that cognitive function might be the only link for the correlation between AD7c-NTP and 25(OH)D. This finding might provide a starting point to investigate the potential value of the interaction between urine AD7c-NTP and serum 25(OH)D in chronic diseases. Further large-scale studies are needed to validate the results of the present study.
Association between serum cystatin C level and cognition in older adults: a cross-sectional analysis

Shuli Wang,Xuechun Lin,Jie Zhou,Meng Li,Dan Song

DOI: https://doi.org/10.3389/fnins.2023.1200763

IF: 4.3

2023-05-04

Frontiers in Neuroscience

Abstract:Introduction: Serum Cystatin C level, an indication of kidney function, has been implicated in the pathogenesis of Alzheimer's disease and cognitive impairment. In this cross-sectional study, we looked into the relation between serum Cystatin C levels and cognition in a group of U.S. older adults. Method: The data of this study were from the National Health and Nutrition Examination Survey (NHANES) 1999–2002. A total of 4,832 older adults aged ≥60 who met the inclusion criteria were included. The Dade Behring N Latex Cystatin C assay, which is a particle-enhanced nephelometric assay (PENIA), was utilized to assess Cystatin C levels in participants' blood samples. Participants' cognition was examined using the digit symbol substitution test (DSST). Z -scores of the DSST were calculated based on sample means and standard deviations (SD). To investigate the relationships between the quartiles of serum Cystatin C level and DSST z scores, multiple linear regression models were developed while controlling for age, sex, race/ethnicity, and education. Results: The average age of the participants was 71.1 (SD 7.8). The participants were about half female (50.5%), non-Hispanic White (61.2%), and (36.1%) who had completed at least some college. They had an average serum Cystatin C level of 1.0 mg/dl (SD 0.44). After performing multiple linear regression with a reference group consisting of participants in quartile one of plasma Cystatin C levels, we found that serum Cystatin C levels in quartiles three and four were independently associated with lower DSST z scores (β = −0.059, 95% CI −0.200 to −0.074 and β = −0.108, 95% CI −0.319 to −0.184, respectively). Conclusion: Higher serum Cystatin C level is associated with worse processing speed, sustained attention, and working memory in older adults. Cystatin C level may be a biomarker for cognitive decline in older adults.

neurosciences
Causal associations of antioxidants with Alzheimer’s disease and cognitive function: a Mendelian randomisation study

Jiao Wang,Yingyue Huang,Chunhua Bei,Huiling Yang,Zihong Lin,Lin Xu

DOI: https://doi.org/10.1136/jech-2023-221184

2024-04-08

Abstract:Background Circulating antioxidants are associated with a lower risk of Alzheimer’s disease (AD) in observational studies, suggesting potential target areas for intervention. However, whether the associations are causal remains unclear. Here, we studied the causality between antioxidants and AD or cognitive function using two-sample Mendelian randomisation (MR). Methods Single nucleotide polymorphisms strongly (p<5×10 −8 ) associated with antioxidants (vitamin A, vitamin C, zinc, selenium, β-carotene and urate) and outcomes (AD, cognitive performance and reaction time) were obtained from the largest and most recent genome-wide association studies (GWAS). MR inverse variance weighting (IVW) and MR pleiotropy residual sum and outlier test (MR-PRESSO) were used for data analysis. Results Higher genetically determined selenium level was associated with 5% higher risk of AD (OR 1.047, 95% CI 1.005 to 1.091, p=0.028) using IVW. Higher genetically determined urate level was associated with worse cognitive performance (β=−0.026, 95% CI −0.044 to −0.008, p=0.005) using MR-PRESSO. No association between the other antioxidants and AD, cognitive performance and reaction time was found. Similar results were found in the sensitivity analyses. Conclusion Our results suggest that lifelong exposure to higher selenium may be associated with a higher risk of AD, and higher urate levels could be associated with worse cognitive performance. Further analyses using larger GWAS of antioxidants are warranted to confirm these observations. Our results suggest that caution is needed in the interpretation of traditional observational evidence on the neuroprotective effects of antioxidants.

public, environmental & occupational health
An investigation into the potential association between nutrition and Alzheimer's disease

Mingyue He,Tenghong Lian,Zhan Liu,Jinghui Li,Jing Qi,Jing Li,Peng Guo,Yanan Zhang,Dongmei Luo,Huiying Guan,Weijia Zhang,Zijing Zheng,Hao Yue,Wenjing Zhang,Ruidan Wang,Fan Zhang,Wei Zhang

DOI: https://doi.org/10.3389/fnut.2024.1306226

2024-03-07

Abstract:Background: Malnutrition is the most common nutritional issue in Alzheimer's disease (AD) patients, but there is still a lack of a comprehensive evaluation of the nutritional status in AD patients. This study aimed to determine the potential association of various nutritional indices with AD at different stages. Methods: Subjects, including individuals with normal cognition (NC) and patients diagnosed with AD, were consecutively enrolled in this cross-sectional study. Demographics, body composition, dietary patterns, nutritional assessment scales and nutrition-related laboratory variables were collected. Binary logistics regression analyses and receiver operating characteristic (ROC) curves were used to indicate the association between nutrition-related variables and AD at different stages. Results: Totals of 266 subjects, including 73 subjects with NC, 72 subjects with mild cognitive impairment due to AD (AD-MCI) and 121 subjects with dementia due to AD (AD-D) were included. There was no significant difference in dietary patterns, including Mediterranean diet and Mediterranean-DASH diet intervention for neurodegenerative delay (MIND) diet between the three groups. Lower BMI value, smaller hip and calf circumferences, lower Mini Nutritional Assessment (MNA) and Geriatric Nutritional Risk Index (GNRI) scores, and lower levels of total protein, albumin, globulin, and apolipoprotein A1 were associated with AD (all p < 0.05). Total protein and albumin levels had the greatest ability to distinguish AD from non-AD (AUC 0.80, 95% CI 0.74-0.84, p < 0.001), increased by combining calf circumference, MNA score and albumin level (AUC 0.83, 95% CI 0.77-0.88, p < 0.001). Albumin level had the greatest ability to distinguish NC from AD-MCI (AUC 0.75, 95% CI 0.67-0.82, p < 0.001), and MNA score greatest ability to distinguish AD-MCI from AD-D (AUC 0.72, 95% CI 0.65-0.78, p < 0.001). Conclusion: Nutritional status of AD patients is significantly compromised compared with normal controls, and tends to be worsened with AD progresses. Early identification and intervention of individuals with nutritional risk or malnutrition may be significantly beneficial for reducing the risk, development, and progression of AD.
Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer’s Disease: A Replication Study and Meta-Analyses

Zi-Xuan Wang,Lan Tan,Hui-Fu Wang,Jing Ma,Jinyuan Liu,Meng-Shan Tan,Jia-Hao Sun,Xi-Chen Zhu,Teng Jiang,Jin-Tai Yu

DOI: https://doi.org/10.3233/jad-143108

2015-01-01

Abstract:To evaluate whether iron, zinc, and copper levels in serum are disarranged in Alzheimer's disease (AD), we performed meta-analyses of all studies on the topic published from 1984 to 2014 and contextually carried out a replication study in serum as well. Our meta-analysis results showed that serum zinc was significantly lower in AD patients. Our replication and meta-analysis results showed that serum copper was significantly higher in AD patients than in healthy controls, so our findings were consistent with the conclusions of four previously published copper meta-analyses. Even if a possible role of iron in the pathophysiology of the disease could not be ruled out, the results of our meta-analysis showed no change of serum iron levels in AD patients, but this conclusion was not robust and requires further investigation. The meta-regression analyses revealed that in some studies, differences in serum iron levels could be due to the different mean ages, while differences in zinc levels appeared to be due to the different sex ratios. However, the effect of sex ratio on serum zinc levels in our meta-analysis is subtle and needs further confirmation. Also, diverse demographic terms and methodological approaches appeared not to explain the high heterogeneity of our copper meta-analysis. Therefore, when investigating trace elements, covariants such as age and sex have to be taken into account in the analyses. In the light of these findings, we suggest that the possible alteration of serum zinc and copper levels are involved in the pathogenesis of AD.
Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer’s Disease

Ma Ling-Zhi,Wang Zi-Xuan,Wang Zuo-Teng,Hou Xiao-He,Shen Xue-Ning,Ou Ya-Nan,Dong Qiang,Tan Lan,Yu Jin-Tai

DOI: https://doi.org/10.1007/s12640-020-00312-y

IF: 3.9781

2020-01-01

Neurotoxicity Research

Abstract:Relationship between serum calcium and Alzheimer’s disease (AD) remains unclear. The aim of this study is to test whether serum calcium is associated with other AD-associated biomarkers and could predict clinical progression in nondemented elders. This was a longitudinal population-based study. The sample was derived from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort, which included 1224 nondemented elders: 413 cognitively normal (CN) and 811 mild cognition impairment (MCI). Associations were investigated between serum calcium and longitudinal changes in Aβ/tau pathologic features, brain structure, cognitive function, and disease progression. Serum calcium concentrations increased with disease severity. Serum calcium predicted longitudinal cognitive decline and conversion from nondemented status to AD dementia (adjusted HR = 1.41, 95% CI 1.13–1.76). Furthermore, serum calcium levels were negatively correlated with CSF-Aβ42 (β = − 0.558, P = 0.008), FDG-PET (β = − 0.292, P < 0.001), whole brain volume (β = − 0.148, P = 0.001), and middle temporal volume (β = − 0.216, P = 0.042). Similar results were obtained in CN and MCI groups. Higher serum calcium status (even if not hypercalcemia) may increase the risk of AD in elders. Serum calcium is a useful biomarker in predicting clinical progression in nondemented elders. More researches are needed in the future to explore the underlying mechanism.

Association of serum vitamin C concentrations with Alzheimer's disease mortality among U.S. adults

Association of Serum Vitamin C Concentrations with Alzheimer’s Disease Mortality among U.S. Adults

Oxidative Stress Markers and Metal Ions Are Correlated with Cognitive Function in Alzheimer’s Disease

The Relation of Serum Vitamin C Concentrations with Alzheimer's Disease Mortality in a National Cohort of Community-Dwelling Elderly Adults

Associations of Serum Albumin with Disability in Activities of Daily Living, Mobility and Objective Physical Functioning Regardless of Vitamin D: Cross-Sectional Findings from the Chinese Longitudinal Healthy Longevity Survey.

Serum 25-Hydroxyvitamin D in Relation to Disability in Activities of Daily Living, Mobility, and Objective Physical Functioning among Chinese Older Adults.

The Impact of Plasma Vitamin C Levels on the Risk of Cardiovascular Diseases and Alzheimer's Disease: A Mendelian Randomization Study.

Association of serum vitamin C with all-cause and cause-specific death: Data from National Health and Nutrition Examination Survey (NHANES 2003-2006)

Combined Associations of Vitamin D and Cognitive Function with All-Cause Mortality among Older Adults in Chinese Longevity Areas: A Prospective Cohort Study.

Low and High Homocysteine Are Associated with Mortality Independent of B Group Vitamins but Interactive with Cognitive Status in a Free-Living Elderly Cohort

The Correlation Between Alzheimer Disease and Levels of Serum Folic Acid and Vitamin B_(12)

Changes in Serum Cystatin C Levels and the Associations With Cognitive Function in Alzheimer's Disease Patients

Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis

Vitamin D Levels and Cognition in Elderly Adults in China.

Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia

Incidental Finding: Urine Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP) and Serum Vitamin D25

Association between serum cystatin C level and cognition in older adults: a cross-sectional analysis

Causal associations of antioxidants with Alzheimer’s disease and cognitive function: a Mendelian randomisation study

An investigation into the potential association between nutrition and Alzheimer's disease

Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer’s Disease: A Replication Study and Meta-Analyses

Serum Calcium Predicts Cognitive Decline and Clinical Progression of Alzheimer’s Disease